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Summary
The increasing levels of antimicrobial resistance among foodborne bacteria are recog-
nised as an important emerging public health problem. Reduced susceptibility to biocides
also appears to be increasing. A potential concern is the possibility that the widespread
use of biocides is responsible for the selection and maintenance of antibiotic-resistant bac-
teria. Here, we examine the prevalence of erythromycin, ciprofloxacin, triclosan, benzalko-
nium chloride, chlorhexidine diacetate, cetylpyridinium chloride, trisodium phosphate and
sodium dodecyl sulphate resistance among 27 isolates of Campylobacter coli and 15 isolates
of Campylobacter jejuni from food, animal, human and environmental water sources. These
antimicrobial susceptibilities were determined by the broth microdilution method. In the
42 Campylobacter strains studied, different antibiotic resistance levels were seen. The resis-
tance to erythromycin and ciprofloxacin was observed in 14.3 % of Campylobacter strains. A
higher rate of erythromycin resistance and multi-resistance was observed among isolated
C. coli than among C. jejuni strains. Similar situations were seen for triclosan. Conversely,
the level of benzalkonium chloride resistance was higher in C. jejuni than in C. coli. No
correlation between biocide and antibiotic resistance was observed. This study does not
provide evidence to confirm that tolerance to biocides is connected to antibiotic resistance
in Campylobacter.
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Introduction
The thermotolerant Campylobacter spp., and especial-
ly Campylobacter coli and Campylobacter jejuni, have be-
come the most commonly reported bacterial cause of
foodborne gastroenteritis in humans worldwide. Usually
they are transmitted to humans by contaminated food
and drinking water (1). As well as this widespread occur-
rence, Campylobacter spp. have become increasingly re-
sistant to antibiotics, including macrolides, fluoroquino-
lones and tetracyclines. These are drugs of choice for the
treatment of clinical campylobacteriosis, so this resistance
greatly compromises the effectiveness of these antibiotic
treatments, indicating a growing public health problem
(2,3).
Biocides comprise various chemical agents that can
efficiently inactivate microorganisms. They are regularly
used in the food industry and in housekeeping to pre-
vent bacterial contamination during food processing, to
disinfect, sanitise and/or sterilise objects and surfaces,
and to preserve materials or processes from microbiol-
ogical contamination (4). In comparison with antibiotic
resistance, the mechanisms of bacterial resistance to bio-
cides have been described more recently and less studied
overall (5,6). However, there are numerous reports of
bacterial resistance to biocides, including resistance to
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triclosan, quaternary ammonium compounds, chlorhexi-
dine and trisodium phosphate (7–9).
A potential concern is the possibility that mechanisms
providing resistance to biocides may also provide cross-
-protection against the activity of antibiotics. Antibiotic
resistance mechanisms, such as reduced cellular uptake,
drug efflux and inactivation, and mutation at a target
site, can also apply to biocides (6,10). A possible link be-
tween biocide and antibiotic resistances in bacteria has
been reported in several studies (11–13). However, con-
trary evidence has appeared in the literature to suggest
that this phenomenon does not cause a real problem in
practice (14–16).
There is a lot of data relating to biocide resistance
among many different bacteria, like Salmonella, Listeria,
and Pseudomonas (13,17,18). However, little is known about
biocide resistance in Campylobacter spp. In this study, we
examine the prevalence of resistance among 27 C. coli
and 15 C. jejuni isolates from food, animal, human and
environmental water sources to a broad range of biocides:
triclosan, benzalkonium chloride (BC), cetylpyridinium
chloride (CPC), chlorhexidine diacetate (CHA) and tri-
sodium phosphate (TSP). We also include the anionic
surfactant sodium dodecyl sulphate (SDS), the microbi-
cide with protein denaturing potency that is added to a
large class of cleaning agents to assist in the cleaning
(19,20). Due to the possibility that biocide resistance is
linked to antibiotic resistance in bacteria, the prevalence
of resistance to the clinically important antibiotics ery-
thromycin and ciprofloxacin will also be examined.
Materials and Methods
Bacterial strains and growth conditions
The 27 C. coli and 15 C. jejuni strains from food, ani-
mal, human and environmental water sources used in
this study were isolated and identified phenotypically and
by multiplex PCR based on amplification of the aspar-
tokinase gene in C. coli and the hippuricase gene in C.
jejuni, as described previously (3,21). The cultures were
stored at –80 °C in brain-heart infusion broth (Biolife,
Milan, Italy) with 20 % horse blood (Oxoid, Hampshire,
UK) and 20 % glycerol (Kemika, Zagreb, Croatia) (22).
The isolates were cultivated at 42 °C under micro-aero-
philic conditions (3 % O2, 10 % CO2 and 87 % N2) in
gas-tight containers on Karmali or Columbia agar, sup-
plemented with 5 % horse blood (Oxoid). C. coli ATCC
33559, C. jejuni ATCC 33560 and NCTC 11168 were used
as reference.
Antimicrobial susceptibility testing
The minimal inhibitory concentrations (MICs) of tri-
closan (Merck, Darmstadt, Germany), BC, CHA, CPC and
TSP (Sigma-Aldrich, St. Louis, MO, USA), SDS (Invitro-
gen, Carlsbad, CA, USA), erythromycin (Sigma-Aldrich)
and ciprofloxacin (Fluka, Buchs, Switzerland) were deter-
mined using the broth microdilution method. This was
carried out in Müller Hinton broth (Oxoid) with inocula
of 106 bacteria/mL using 96-well microtitre plates, as de-
scribed previously (23). Ethanol (Merck) was used as the
erythromycin and triclosan co-solvent, at concentrations
previously shown to be non-inhibitory for bacterial cells.
Twofold serial dilutions of erythromycin, ciprofloxacin,
triclosan and BC were used at concentrations of 0.016 to
512 mg/mL, of CHA and CPC at 0.016 to 2 mg/mL, of
SDS at 0.125 to 1024 mg/mL, and of TSP at 0.5 to 64
mg/mL. The microtitre plates were incubated for 24 h at
42 °C under microaerophilic conditions. The MICs were
defined as the lowest concentration of the antimicrobial
drug where no viable cells were present, and they were
determined on the basis of the fluorescent signal meas-
ured by the microplate reader (Tecan, Männedorf, Switz-
erland) after adding 20 mL CellTiter-Blue® Reagent (Pro-
mega, Madison, WI, USA) to the culture media, following
the manufacturer’s instructions. The assays were repeat-
ed twice in duplicate, to confirm the reproducibility of
these MIC data.
The antibiotic resistance breakpoints were defined
according to the recommendations of the Clinical and
Laboratory Standards Institute (24). The breakpoints are
shown in Table 1. Multi-resistance was defined as the
resistance to erythromycin and ciprofloxacin. Sensitive
strains were those susceptible to erythromycin and cipro-
floxacin. C. coli ATCC 33559, C. jejuni ATCC 33560 and
NCTC 11168 reference strains were used as susceptibility
test control.
Statistical analysis of MIC data
Statistical analyses were performed with IBM® SPSS®
software v. 17.0 (IBM Corporation, Armonk, NY, USA).
The MICs of antimicrobial assays were compared with
the independent samples t-test to prove or disprove the
significance of the differences in resistance between C.
coli and C. jejuni, and between strains sensitive and re-
sistant to antibiotics, as well as between sensitive and
multi-resistant strains. The correlation of antibiotic and
biocide MIC distributions was compared by Pearson’s c2
test. Results were considered significant when p³0.05. A
Pearson’s correlation coefficient was calculated for the
correlation matrix between biocide and antibiotic MIC
distributions.
Results and Discussion
In total, 42 C. coli and C. jejuni isolates from food,
animal, human and environmental water sources were
tested for their susceptibilities to erythromycin, ciproflox-
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Table 1. The range of concentrations of biocides and antibiotics







benzalkonium chloride (BC) 0.016–4
cetylpyridinium chloride (CPC) 0.25–4
chlorhexidine diacetate (CHA) 0.063–2
trisodium phosphate (TSP) 2000–16000
sodium dodecyl sulphate (SDS) 128–1024
erythromycin 0.125–1024 >32
ciprofloxacin 0.125–128 >4
acin, five biocides (triclosan, BC, CHA, CPC and TSP)
and an anionic surfactant SDS. The range of concentra-
tions for antibiotics and biocides (in twofold increases)
and the breakpoints for antibiotics are shown in Table 1.
With regard to antibiotic resistances of these Cam-
pylobacter strains, 33 out of the 42 strains (78.6 %) were
susceptible and 9 out of 42 (21.4 %) were resistant to
erythromycin, and half of these strains tested (51.4 %)
were resistant to ciprofloxacin. The resistance to both anti-
biotics tested was observed in 6 out of 42 (14.3 %) tested
strains. The erythromycin resistance data determined in
our previous study (23) were in some cases different
from those obtained in the present study. Instability of
the erythromycin resistance phenotype was observed in
three C. coli strains: VC7114, VC110722 and VC110725.
Erythromycin resistance (MIC>512 mg/mL) was deter-
mined in strain VC7114 in our previous antimicrobial
testing, while no resistance (MIC=1 mg/mL) was seen in
further investigations with the same method. Addition-
ally, previous erythromycin medium-level resistance of
strains VC110722 and VC110725 dropped from 8 mg/mL
to a sensitive phenotype (4 and 2 mg/mL, respectively).
A similar situation was reported previously (23), where
we reported the presence of the A2075G mutation in the
23S rRNA gene as responsible for this erythromycin resis-
tance. No mutation has been identified in any sensitive
strain, as well as in the resistant strain VC7114, which
appears to have an unstable resistance phenotype. This
reduction of the erythromycin resistance to a sensitive
phenotype occurred only in C. coli. These data suggest
that there is erythromycin resistance that is not mediat-
ed by the A2075G mutation in the 23S rRNA gene but
by other mechanism(s), and that this might be condi-
tionally (temporarily) induced to provide the bacterial
pathogens with rapid adaptation to environmental chan-
ges. As with our findings, other studies have reported
unstable phenotypes: Campylobacter mutants that show
low-to-intermediate levels of erythromycin resistance
and lack 23S rRNA mutations were not stable in culture
media or on the animal host, and easily lost their re-
sistance phenotype in the absence of macrolide antibio-
tics (25–27).
There is a lot of data available that relate to biocide
resistance among different foodborne pathogenic bacte-
ria; however, the data about biocide resistance in Cam-
pylobacter spp. are scarce. This study of 42 Campylobacter
strains from different sources indicates that there is bio-
cide resistance in C. coli and C. jejuni. Since there is nei-
ther literature data about breakpoints of resistance levels
to biocides, the MICs in the Campylobacter spp. in the
present study were compared to MICs determined in
other bacteria.
In the present study, the MICs of triclosan among C.
coli and C. jejuni strains ranged from 8 to 64 mg/mL. In
this way, these data resemble the recently reported ob-
servations for strains of Salmonella enterica, where three
distinct triclosan resistance phenotypes were observed:
triclosan low-level resistance (MIC³8 mg/mL), triclosan
medium-level resistance (MIC=16–32 mg/mL), and triclo-
san high-level resistance (MIC>32 mg/mL) (8,11,28).
In 41 of the 42 strains tested (97.6 %), BC MICs were
between 0.016 and 2.0 mg/mL. Only one human clinical
multi-resistant isolate had a MIC of 4 mg/mL for BC.
These data for BC susceptibility are similar to those re-
ported for Listeria monocytogenes food and industrial iso-
lates, where two BC resistance phenotypes were observed:
BC sensitive with MICs of 2 mg/mL or below and BC
resistant with MICs of 4 mg/mL or above (17,29). The
same situation was observed for CPC, another biocide
from the group of quaternary ammonium compounds that
was tested in this study. However, no statistically signi-
ficant correlation between the resistances of these tested
strains to these two biocides was seen. The MIC values
for triclosan, BC, CPC and CHA in our isolates were lower
than those reported for Acinetobacter, Citrobacter and Pseu-
domonas industrial isolates (15), Pseudomonas stutzeri (18),
and Campylobacter isolates from slaughterhouses (30). In
these previous studies the MICs for triclosan ranged from
4 to above 100 mg/mL, the MICs for BC from 0.5 to 340
mg/mL, for CPC from 2.5 to 250 mg/mL and for CHA
from 1 to 100 mg/mL. However, these other MICs were
determined using the agar dilution method, which is
known to give higher values than the MICs determined
in broth (29).
The distributions of antibiotic and biocide MICs
across C. coli and C. jejuni are presented in Table 2. A
significant difference in erythromycin resistance was ob-
served between C. coli (29.6 %) and C. jejuni (6.7 %) (t-test,
p=0.019). Moreover, a higher rate of multi-resistance was
found in C. coli (20.8 %) than in C. jejuni (6.7 %). Higher
rates of erythromycin resistance among C. coli than among
C. jejuni had been reported previously (3,16,23,31). A si-
milar situation was observed for the triclosan resistance.
C. coli strains were in general more resistant than C.
jejuni strains (t-test, p=0.02). Conversely, the level of BC
resistance was higher in C. jejuni than in C. coli (t-test,
p=0.021). However, there were no significant differences
among C. coli and C. jejuni strains for other tested bio-
cides, SDS and ciprofloxacin. Cases of linked biocide
and antibiotic resistances (10,11,32) and a lack of any
such link (14–16) have already been reported in the lite-
rature. Resistance to the clinically important antibiotics
erythromycin and ciprofloxacin in Campylobacter spp.
might also be attributed to its active efflux (23), which is
known to mediate multidrug resistance to antibiotics and
disinfectants in bacteria (11,12,33). To investigate cross-
-resistance to antibiotics and biocides, Campylobacter strains
with different resistance levels to erythromycin and ci-
profloxacin were included in this study. The distributions
of different biocide MICs across the erythromycin- and
ciprofloxacin-sensitive and -resistant strains, as well as
across sensitive and multi-resistant strains are presented
in Table 3. The overall level of biocide resistance was
not significantly different in strains with different anti-
biotic resistance level (t-test, p>0.05), with an exception
of SDS. Interestingly, a higher level of SDS resistance was
found in erythromycin-sensitive than in erythromycin-
-resistant, as well as in sensitive than in multi-resistant
strains (t-test, p=0.035 and p=0.007, respectively). A Pear-
son’s correlation matrix was calculated for two distribu-
tions of antibiotics, six distributions of biocides and SDS.
A statistically significant correlation between MIC distri-
bution of CPC and CHA (p=0.002, Rxy=0.47), and of CPC
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Table 2. The distribution of MICs of biocides tested in C. coli and C. jejuni
Biocide/antibiotic Distribution of MIC/%
g(triclosan)/(mg/mL) 8 16 32 64
C. coli 0 14.8 59.3 25.9
C. jejuni 13.3 33.3 46.7 6.7
total 4.8 21.4 54.8 19
g(BC)/(mg/mL) 0.016 0.063 0.25 0.5 1 2 4
C. coli 0 3.7 28.6 44.4 22.2 0 0
C. jejuni 6.7 6.7 0 6.7 60 13.3 6.7
total 2.4 4.8 19 31 35.7 4.8 2.4
g(CPC)/(mg/mL) 0.25 0.5 1 2 4
C. coli 7.4 37 22.2 29.6 3.7
C. jejuni 13.3 13.3 26.7 46.7 0
total 9.5 28.6 23.8 35.7 2.4
g(CHA)/(mg/mL) 0.063 0.125 0.25 0.5 1 2
C. coli 3.7 18.5 37 33.3 3.7 3.7
C. jejuni 0 20 40 33.3 6.7 0
total 2.4 19 38.1 33.3 4.8 2.4
g(TSP)/(mg/mL) 2 4 8 16
C. coli 0 3.7 55.6 37
C. jejuni 6.7 20 55.3 26.7
total 2.4 9.5 54.8 33.3
g(SDS)/(mg/mL) 128 256 512 1024
C. coli 3.1 55.5 25.9 14.8
C. jejuni 6.7 40 53.3 0
total 4.8 50 35.7 9.5
g(erythromycin)/(mg/mL) 0.125 0.25 0.5 1 2 4 512 1024
C. coli 11.1 11.1 14.8 14.8 14.8 1 11.1 18.5
C. jejuni 6.7 13.3 53.3 20 0 0 6.7 0
total 9.5 11.9 28.6 16.6 4 1 9.5 11.9
g(ciprofloxacin)/(mg/mL) 0.063 0.125 0.25 1 2 4 8 16 32 64 128
C. coli 4.5 13.6 13.6 0 0 9.1 4.5 22.7 22.7 4.5 4.5
C. jejuni 0 20 13.3 13.3 6.7 6.7 20 13.3 0 0 6.7
total 2.7 16.2 13.5 5.4 2.7 8.1 10.8 18.9 13.5 2.7 5.4
Table 3. The distribution of MICs of biocides tested in antibiotic-sensitive, antibiotic-resistant and multi-resistant Campylobacter strains
Biocide Distribution of MIC/%
g(triclosan)/(mg/mL) 8 16 32 64
erythromycin-sensitive 3 27.3 51.5 18.2
erythromycin-resistant 11.1 0 66.7 22.2
ciprofloxacin-sensitive 5.6 33.3 38.9 16.7
ciprofloxacin-resistant 5.3 10.5 57.9 26.3
sensitive 6.7 40 40 13.3
multi-resistant 16.7 0 66.7 16.7
g(BC)/(mg/mL) 0.016 0.063 0.25 0.5 1 2 4
erythromycin-sensitive 3 3 18.2 33.3 36.4 6.1 0
erythromycin-resistant 0 11.1 22.2 22.2 33.3 0 11.1
ciprofloxacin-sensitive 5.6 5.6 11.1 27.8 38.9 11.1 0
ciprofloxacin-resistant 0 5.3 21.1 26.3 42.1 0 5.3
sensitive 6.7 6.7 6.7 26.7 40 13.3 0
multi-resistant 0 16.7 16.7 16.7 33.3 0 16.7
and TSP (p=0.014, Rxy=0.376) was observed. Another cor-
relation was seen for triclosan and BC (p=0.048, Rxy=
–0.307) and for ciprofloxacin and SDS (p=0.05, Rxy=–0.307).
No statistically significant correlation was observed be-
tween antibiotic and biocide MICs.
Conclusion
The results of our study demonstrate that there is
antimicrobial resistance among thermotolerant Campylo-
bacter spp. Higher rates of erythromycin resistance were
found among C. coli than C. jejuni isolates, which is in
agreement with previously published data (3,16,23). A
similar situation was observed for triclosan resistance. A
comparison of our data on erythromycin resistance in
Campylobacter spp. in this and our previous study (23)
indicates the appearance of unstable resistance to eryth-
romycin among C. coli that is not mediated by mutations
in 23S rRNA. Therefore, the erythromycin resistance is
also mediated by other mechanism(s). As erythromycin
is an antibiotic of choice for the treatment of clinical
campylobacteriosis, this temporarily induced mechanism
might greatly compromise the effectiveness of such anti-
biotic treatment, which could cause a serious public health
problem. The present study does not provide evidence
to confirm that tolerance to biocides is connected to anti-
biotic resistance in Campylobacter spp. Findings obtained
in the present study and the reported occurrence of cross-
-resistance to disinfectants and antibiotics among patho-
gens, and to common resistance mechanisms, like non-
-specific active efflux (4,11,31,33), indicate the need to
further monitor the prevalence of antibiotic resistance and
biocide resistance of zoonotic bacteria in food, animals
and humans. The data obtained in such comprehensive
epidemiological studies should contribute to better trace-
ability and understanding of the phenomenon of biocide
and antibiotic resistance, and the links between them,
and they would highlight the need for prudent use of
antimicrobials in different areas of work, including the
food production chain.
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Biocide Distribution of MIC/%
g(CPC)/(mg/mL) 0.25 0.5 1 2 4
erythromycin-sensitive 9.1 30.3 18.2 39.4 3
erythromycin-resistant 11.1 22.2 44.4 22.2 0
ciprofloxacin-sensitive 16.7 33.3 5.6 44.4 0
ciprofloxacin-resistant 5.3 15.8 42.1 36.8 0
sensitive 13.3 33.3 6.7 46.7 0
multi-resistant 0 16.7 66.7 16.7 0
g(CHA)/(mg/mL) 0.063 0.125 0.25 0.5 1 2
erythromycin-sensitive 3 18.2 33.3 39.4 3 3
erythromycin-resistant 0 22.2 55.6 22.2 0 0
ciprofloxacin-sensitive 0 16.7 33.3 44.4 5.6 0
ciprofloxacin-resistant 5.3 21.1 47.3 21.1 5.3 0
sensitive 0 13.3 46.7 33.3 6.7 0
multi-resistant 0 16.7 66.7 16.7 0 0
g(TSP)/(mg/mL) 2 4 8 16
erythromycin-sensitive 3 9.1 51.5 36.4
erythromycin-resistant 0 11.1 66.7 22.2
ciprofloxacin-sensitive 5.6 11.1 66.7 16.7
ciprofloxacin-resistant 0 5.3 47.4 47.4
sensitive 6.7 6.7 66.7 13.3
multi-resistant 0 0 66.7 33.3
g(SDS)/(mg/mL) 128 256 512 1024
erythromycin-sensitive 6.1 42.4 39.4 12.1
erythromycin-resistant 0 77.8 22.2 0
ciprofloxacin-sensitive 5.6 33.3 50 11.1
ciprofloxacin-resistant 5.3 68.4 21.1 5.3
sensitive 6.7 33.3 46.7 13.3
multi-resistant 0 100 0 0
Table 3. – continued
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